Allison Arthur, MD, FAAD, discusses strategies for PAs and supervising physicians to effectively collaborate to optimize patient care, improve job satisfaction, and reduce burn-out.

At the end of this podcast, you will have gained the ability to:

• Discuss different ways that PAs and physicians can work together in an outpatient dermatology practice.
• Describe strategies for collaborating on difficult patient cases.
• Explore ways to share knowledge for mutual professional development.

Allison Arthur is a double board-certified dermatologist and dermatopathologist, and owner of Sand Lake Dermatology Center in Orlando, Florida.

Heather W. Goff, MD, MPH, explores the concept of the "uncanny valley" and the influence of social media on patient aesthetic preferences in this podcast. She also examines the role of 'trust' in medical and social media communication, highlighting the ethical challenges encountered by professionals in cosmetic dermatology.

Heather Woodworth Goff, MD, MPH, is an associate professor in the Department of Dermatology at UT Southwestern Medical Center, boasts specialized knowledge in the assessment and management of cutaneous lymphoma.

Heather Woodworth Goff, MD, MPH, Medical Director of the Nashville Conference, initiates this discussion by sharing insights into selecting a medical specialty during training. She advises listeners to steer clear of feeling intimidated by certain diseases and instead encourages them to embrace the challenges posed by ailments that may be less desired for treatment. Dr. Goff, an associate professor in the Department of Dermatology at UT Southwestern Medical Center, boasts specialized knowledge in the assessment and management of cutaneous lymphoma.

Upon concluding this podcast, participants will be empowered to:

• Identify the typical clinical manifestations exhibited by cutaneous T-cell lymphomas.
• Outline primary and secondary treatment options for mycosis fungoides.
• Discriminate between the patch and plaque stages of the disease.
• Enumerate the different disease states and clinical characteristics that differentiate CD30+ lymphoproliferative disorders.

· Identify clinical presentations associated with poorer outcomes and recognize the features indicative of patients likely to undergo disease progression.